Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring ...

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted ...

Novo Nordisk's sales of Wegovy surpassed expectations, calming investor concerns about competition from Eli Lilly. Shares ...

Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce body weight ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

Novo Nordisk's blockbuster diabetes drug Ozempic may reduce the risk of developing ... Semaglutide, the active ingredient in Ozempic, was associated with a 40% to 70% lower risk of a first-time ...

Novo's Wegovy and diabetes drug Ozempic, both known chemically as ... Bloomberg news reports 9:40 PM UTC · Updated ago Legalcategory US indicts founder of crypto firm Gotbit for alleged market ...

Drugs such as Novo Nordisk’s blockbuster Ozempic can cut drug and alcohol abuse by up to ... The study found that those taking the drugs had a 40% lower rate of opioid overdose compared with ...

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other ... The Gefion machine, which uses 65 kilometers (40 miles) of cable and weighs ...

Drugs such as Novo Nordisk’s blockbuster Ozempic can cut drug and alcohol abuse by up to 50% according to a new study, adding to mounting evidence that the drugs yield health benefits beyond ...

Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s ...

Major risks to consider in this sector are drug side effects, the lengthy research and regulatory process, and brand reputation affected by recalls. Novo Nordisk (NVO) presents an opportunity to ...